DE60335270D1 - Pharmaceutical forms for delayed release with two nuclears and one opening - Google Patents

Pharmaceutical forms for delayed release with two nuclears and one opening

Info

Publication number
DE60335270D1
DE60335270D1 DE2003635270 DE60335270A DE60335270D1 DE 60335270 D1 DE60335270 D1 DE 60335270D1 DE 2003635270 DE2003635270 DE 2003635270 DE 60335270 A DE60335270 A DE 60335270A DE 60335270 D1 DE60335270 D1 DE 60335270D1
Authority
DE
Germany
Prior art keywords
nuclears
opening
delayed release
pharmaceutical forms
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE2003635270
Other languages
German (de)
Inventor
Harry S Sowden
Gerard P Mcnally
David Wynn
Oliver Anderson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johnson and Johnson Consumer Inc
Original Assignee
Johnson and Johnson Consumer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to PCT/US2002/031024 priority Critical patent/WO2003026625A1/en
Priority to PCT/US2002/031062 priority patent/WO2003026626A2/en
Priority to PCT/US2002/031163 priority patent/WO2003026627A1/en
Priority to PCT/US2002/031117 priority patent/WO2003026629A2/en
Priority to PCT/US2002/031129 priority patent/WO2003026630A1/en
Priority to PCT/US2003/008894 priority patent/WO2004028508A1/en
Application filed by Johnson and Johnson Consumer Inc filed Critical Johnson and Johnson Consumer Inc
Application granted granted Critical
Publication of DE60335270D1 publication Critical patent/DE60335270D1/en
Application status is Active legal-status Critical
Anticipated expiration legal-status Critical

Links

DE2003635270 2001-09-28 2003-03-21 Pharmaceutical forms for delayed release with two nuclears and one opening Active DE60335270D1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
PCT/US2002/031062 WO2003026626A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031163 WO2003026627A1 (en) 2001-09-28 2002-09-28 Composite dosage forms
PCT/US2002/031117 WO2003026629A2 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2002/031129 WO2003026630A1 (en) 2001-09-28 2002-09-28 Dosage forms having an inner core and outer shell with different shapes
PCT/US2002/031024 WO2003026625A1 (en) 2001-09-28 2002-09-28 Modified release dosage forms
PCT/US2003/008894 WO2004028508A1 (en) 2002-09-28 2003-03-21 Modified release dosage forms with two cores and an opening

Publications (1)

Publication Number Publication Date
DE60335270D1 true DE60335270D1 (en) 2011-01-20

Family

ID=34271652

Family Applications (2)

Application Number Title Priority Date Filing Date
DE2003629614 Active DE60329614D1 (en) 2001-09-28 2003-03-21 Polymeric composition and pharmaceutical forms containing thereof
DE2003635270 Active DE60335270D1 (en) 2001-09-28 2003-03-21 Pharmaceutical forms for delayed release with two nuclears and one opening

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE2003629614 Active DE60329614D1 (en) 2001-09-28 2003-03-21 Polymeric composition and pharmaceutical forms containing thereof

Country Status (8)

Country Link
JP (3) JP2006517514A (en)
CN (3) CN1684671A (en)
AT (1) AT444739T (en)
AU (4) AU2003225944A1 (en)
BR (5) BR0314777A (en)
CA (3) CA2500311A1 (en)
DE (2) DE60329614D1 (en)
MX (1) MXPA05003283A (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2470463C (en) 2004-06-09 2012-09-18 Lornamead Brands, Inc. Tooth whitening products and methods of making the same
US20110195121A1 (en) * 2008-06-19 2011-08-11 Seshni Sewlall chronotherapeutic pharmaceutical dosage form
SA2709B1 (en) * 2006-08-25 2011-07-20 بيورديو فارما إل. بي. Tamper Resistant Oral Pharmaceutical Dosage Forms Comprising an Opioid Analgesic
WO2011118454A1 (en) * 2010-03-23 2011-09-29 リンテック株式会社 Solid preparation
WO2013009701A2 (en) * 2011-07-08 2013-01-17 The University Of North Carolina At Chapel Hill Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
EP2811985B1 (en) * 2012-02-07 2018-10-17 Johnson & Johnson Consumer Inc. Rapidly disintegrating coated tablets
TW201400146A (en) * 2012-06-05 2014-01-01 Takeda Pharmaceutical Core-containing tablet
CN107148268A (en) * 2014-09-19 2017-09-08 宝洁公司 Pulse release neo-synephrine formulation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0662824A1 (en) * 1992-09-30 1995-07-19 Pfizer Inc. Article containing a core and a coating having a non constant thickness
GB9402203D0 (en) * 1994-02-04 1994-03-30 Smithkline Beecham Plc Pharmaceutical formulation
DE4431653C2 (en) * 1994-09-06 2000-01-20 Lohmann Therapie Syst Lts The coated tablet for controlled release of active substances, a process for their preparation and their use
IT1282576B1 (en) * 1996-02-06 1998-03-31 Jagotec Ag Pharmaceutical tablet capable of releasing the active substance in subsequent and predeterminable times
US6602521B1 (en) * 1998-09-29 2003-08-05 Impax Pharmaceuticals, Inc. Multiplex drug delivery system suitable for oral administration
JPWO2001078681A1 (en) * 2000-04-17 2004-01-08 山之内製薬株式会社 Drug delivery system and method for avoiding the pharmacokinetic drug interactions
AU2002228579B2 (en) * 2001-02-13 2006-07-27 Astrazeneca Ab Novel modified released formulation

Also Published As

Publication number Publication date
AU2003220466A1 (en) 2004-04-19
CN1700908A (en) 2005-11-23
JP2006517514A (en) 2006-07-27
AU2003220472A1 (en) 2004-04-19
AU2003225944A1 (en) 2004-04-19
DE60329614D1 (en) 2009-11-19
MXPA05003283A (en) 2005-11-23
BR0314547A (en) 2005-08-09
BR0314787A (en) 2005-07-26
CA2500312A1 (en) 2004-04-08
CN1684671A (en) 2005-10-19
BR0314777A (en) 2005-07-26
AU2003218359A1 (en) 2004-04-19
AT444739T (en) 2009-10-15
JP2006517182A (en) 2006-07-20
CA2500313C (en) 2011-06-07
BR0314781A (en) 2005-07-26
JP2006517183A (en) 2006-07-20
CA2500313A1 (en) 2004-04-08
BR0314804A (en) 2005-08-02
CA2500311A1 (en) 2004-04-08
CN1700907A (en) 2005-11-23

Similar Documents

Publication Publication Date Title
DK1348411T3 (en) Ostomian device with external closure
GB2379116B (en) Synchronised cameras with auto-exchange
DE60239289D1 (en) Capsule with fast solubility and release
DE60300647D1 (en) Lighting device and its use
DE60315892D1 (en) Phosphono-oxy-chinazoline derivatives and their pharmaceutical use
DE60334900D1 (en) Drugs donors
EP1890609B8 (en) Locator and closure device
DE60330322D1 (en) MEDICINES microparticles
DE60318860D1 (en) Chinucledin derivatives and their use
DE60325511D1 (en) Depot formulations with delayed release
DE60312201D1 (en) Drugs donors
DE60117801D1 (en) Pharmaceutical composition with controlled release and delayed absorption
DE60326611D1 (en) N and the equal
DE60325354D1 (en) Topic applicable pharmaceutical preparation
DE60326124D1 (en) Device and arrangement for the mitralklappenreparatur
DE60133538D1 (en) Formulation and tablets with guaifenesine with delayed release
DE60321386D1 (en) Pharmaceutical preparation for modified release
DE60311552D1 (en) Depilatories and their use
AT356506T (en) Event reminder procedure
IL182554D0 (en) Anti-addl antibodies and uses thereof
LU92182I2 (en) Dapagliflozin and its pharmaceutically acceptable salts
LU93093I2 (en) Necitumumab and its pharmaceutically acceptable derivatives (portrazza)
RU2007134596A (en) Non-spilling drinkers
IL225633D0 (en) Anti-alpha-v-beta - 6 antibodies and uses thereof
DE60222734D1 (en) Microparticles and process for their preparation